Automation
Architecture review before implementation
Implementation scope and rollout planning
Clear next-step recommendation
This page details a custom automation workflow that systematically identifies pediatric trial cohorts by orchestrating EHR queries, age-stratified logic, and feasibility forecasting to replace manual chart reviews and enrollment modeling.
Manual pediatric cohort identification is a high-cost bottleneck, delaying trial starts and increasing site burden. This workflow automates the ingestion and harmonization of pediatric EHR data from Epic or Cerner, applying protocol-specific logic for age bands, weight-based dosing, and guardian consent dynamics. It replaces weeks of manual chart review with a systematic, query-driven process, directly reducing enrollment delays and improving candidate match quality for sponsors and CROs.
Implementation integrates with clinical data warehouses and uses agentic frameworks like LangGraph to manage state across screening steps. The architecture includes controls for data quality validation, exception routing for complex cases, and audit trails for regulatory compliance. By forecasting cohort size and site feasibility before activation, sponsors de-risk pediatric studies and accelerate time-to-first-patient-in, turning a fragmented manual process into a scalable, data-driven operating model.
Automating pediatric cohort stratification and feasibility analysis directly addresses the most costly delays and operational bottlenecks in pediatric clinical research, turning a manual, high-risk process into a predictable, scalable operating model.
Manual pediatric feasibility requires weeks of chart review and manual data aggregation across sites to estimate eligible population size. An automated workflow ingests and harmonizes EHR data, applies protocol logic, and generates a prevalence report in hours. This compresses the critical path from protocol finalization to site activation, allowing studies to initiate months faster and capture first-patient-in milestones ahead of schedule.
Manual screening for age-stratified pediatric cohorts is labor-intensive, requiring coordinators to manually verify age bands, weight-based dosing eligibility, and guardian dynamics. An agentic workflow automates this initial pass, applying complex temporal logic (e.g., age-at-consent vs. age-at-randomization) and flagging only high-potential candidates for human review. This shifts site staff from data mining to patient engagement, dramatically lowering per-patient screening labor costs.
Pediatric protocols have nuanced criteria around developmental stages, prior treatments, and concomitant medications that are easily missed in manual review. An automated workflow performs consistent, exhaustive checks against the full protocol logic and longitudinal patient history, ensuring only truly eligible patients are referred for screening. This increases the signal-to-noise ratio for sites, reducing costly screen failures and improving the statistical power of the enrolled cohort.
Pediatric enrollment is notoriously unpredictable. An automated feasibility workflow continuously models enrollment against real-world data, identifying geographic gaps or protocol criteria that are too restrictive. It enables proactive simulation of protocol amendments (e.g., broadening age bands) and predictive site performance forecasting. This transforms enrollment from a reactive gamble into a managed process, protecting multi-million-dollar trial budgets from costly extensions.
Pediatric trials require navigating multi-party consent (guardians, assents) and complex family structures. An automated workflow integrates with patient portals and eConsent platforms to orchestrate the consent journey, verifying guardian authority and managing document routing based on jurisdictional rules. This reduces administrative errors, accelerates the consent process, and creates a defensible audit trail for regulators, reducing compliance risk.
Manually aggregating data across pediatric hospitals for a national study is a compliance and logistical nightmare. A custom workflow uses federated querying or privacy-preserving record linkage (PPRL) techniques to execute feasibility queries across decentralized EHRs (Epic, Cerner) without moving PHI. This enables scalable patient finding across networks while maintaining strict HIPAA/GDPR compliance, turning a governance barrier into a strategic advantage.
This page details the solution architecture for a custom automation workflow that identifies and stratifies pediatric patients for clinical trials, accounting for age bands, weight-based dosing, and guardian consent dynamics to reduce enrollment delays and improve candidate quality.
This multi-agent system automates the complex, manual bottleneck of pediatric cohort identification by orchestrating queries across EHRs (Epic, Cerner), genomic data lakes, and clinical narratives. It replaces weeks of manual chart review with a rule-governed workflow that applies protocol-specific logic for age stratification, weight-based dosing eligibility, and consent status checks. The operational upside comes from faster site activation, higher screen-to-randomization rates, and reduced administrative burden on clinical coordinators, directly compressing trial timelines and lowering per-patient acquisition cost.
Implementation integrates with Veeva Vault CTMS and EDC systems via API agents, with the orchestration layer built on LangGraph for state management. The architecture includes mandatory human-in-the-loop gates for physician review of matched cohorts and an automated audit trail logging all decisions for regulatory inspection. Continuous compliance monitoring agents validate each step against HIPAA and 21 CFR Part 11, while synthetic data pipelines allow for feasibility testing and workflow simulation before live deployment on protected health information.
A custom pediatric cohort workflow requires specialized agents to handle age bands, weight-based dosing, and guardian consent logic. This architecture connects EHR data, feasibility models, and matching engines to reduce enrollment delays and improve candidate quality.
This agent orchestrates the ingestion and normalization of pediatric-specific data from Epic, Cerner, and other EHRs. It maps growth charts, developmental milestones, and vaccination histories into a structured format, applying age-specific data quality checks to flag inconsistencies in weight-for-age or height-for-age percentiles before cohort queries run.
A rules-based agent that parses complex pediatric trial protocols to extract and codify age-band definitions, weight-based dosing schedules, and guardian consent requirements. It translates narrative criteria into executable logic for the matching engine, handling nested conditions like '≥2 years to <12 years, stratified by Tanner Stage'.
This system agent queries harmonized RWD/EHR data to model the addressable patient population for a proposed protocol. It simulates enrollment curves across different age strata and geographic sites, identifying potential recruitment gaps before site activation. Integrates with tools like TriNetX or custom RWE platforms.
A specialized workflow component that manages the complex consent logic for pediatric trials. It verifies guardian relationships from EHR data, determines state-specific minor assent requirements, and routes eConsent documents and workflows appropriately. This agent ensures regulatory compliance is baked into the matching pipeline.
The core orchestration layer that executes the stratified matching logic. For each patient candidate, it scores eligibility across all active pediatric study arms, accounting for age, weight, prior conditions, and proximity to sites. Outputs a ranked list of matches with confidence scores and evidence for physician review.
A control-plane agent that manages the human-in-the-loop review process. It presents matched candidates to investigators via integrated dashboards (e.g., within Epic or a standalone portal), captures approval/rejection decisions, and routes complex exceptions (e.g., off-protocol waivers) to the appropriate medical monitor or sponsor for escalation.
A phased implementation strategy for pediatric trial automation, designed to deliver value incrementally while managing clinical and technical risk.
Phase 1 establishes the core data ingestion and harmonization layer, connecting to primary EHRs like Epic or Cerner and normalizing pediatric-specific fields (DOB, weight, guardian contacts). This initial orchestration, built with LangGraph, focuses on creating a clean, query-ready patient index. The goal is to validate data quality and pipeline reliability before introducing complex matching logic, delivering immediate value by automating manual chart pulls for feasibility assessments.
Phase 2 layers on the age-stratified matching logic and feasibility forecasting agent, which models cohort size against protocol criteria. Phase 3 integrates with downstream CTMS and EDC systems (e.g., Veeva) and implements the physician review gateway and guardian consent workflow. Each phase concludes with a validation checkpoint against historical trial data, ensuring the automation meets clinical safety and operational throughput targets before broader rollout.
Comparison of manual vs. custom automated workflow for pediatric cohort identification, highlighting cycle time, labor leverage, and compliance gains.
| Metric | Manual Process (Current State) | Custom Automated Workflow |
|---|---|---|
Feasibility Assessment Cycle Time | 4-6 weeks | 3-5 days |
Patient Screening Cost per Candidate | $220-$350 | $45-$75 |
Manual Chart Review Required | 100% of records | < 20% (exception routing only) |
Protocol-to-Cohort Match Accuracy | ~75% (prone to oversight) |
|
Audit Trail for Matching Decisions | Spreadsheets, email threads | Immutable, queryable logs |
Time to Identify Rare Disease Cohort | 6-12 months | 2-4 weeks |
Consent & Guardian Dynamics Tracking | Manual follow-up, high drop-off | Automated status tracking & alerts |
Practical questions about building and operating a custom pediatric trial feasibility and matching automation workflow.
The workflow architecture includes dedicated data validation agents that run before any matching logic. These agents check for missing age/weight fields, implausible values (e.g., weight for a 2-year-old), and inconsistent units. Records failing validation are routed to an exception queue for human data steward review and correction. The matching engine only processes validated records, ensuring downstream decisions are based on reliable data. We also implement feedback loops where corrections from the exception queue are used to retrain validation models.
Enabling Efficiency, Speed & Accuracy
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
This page details the governance architecture and phased rollout strategy for a custom pediatric cohort automation workflow, ensuring compliance and operational safety in high-stakes clinical research.
This workflow automates the complex matching of pediatric patients to age-stratified trial arms, a process historically bottlenecked by manual chart reviews for age bands, weight-based dosing, and guardian consent status. The operational upside comes from dramatically reducing enrollment timelines and improving match accuracy, directly impacting study feasibility and cost. Implementation requires a multi-agent architecture integrated with EHRs (Epic, Cerner) and clinical trial management systems, where specialized agents handle data harmonization, eligibility logic, and feasibility forecasting under strict governance controls.
Rollout is sequenced, beginning with a single-site pilot using synthetic data to validate matching logic and bias detection before progressing to live PHI. Controls are embedded at each layer: automated bias monitoring in screening algorithms, immutable audit trails for all matching decisions, and mandatory human-in-the-loop review by a study clinician before any patient contact. The final architecture must support explainability reports for each eligibility flag to satisfy IRB and regulatory scrutiny, turning a high-risk manual process into a governed, scalable operating model.
About the author
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
How We Work
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
The first call is a practical review of your use case and the right next step.
